메뉴 건너뛰기




Volumn 32, Issue 2, 2012, Pages 114-119

Hepatitis B virus and HIV infection

Author keywords

chronic hepatitis B virus; drug resistance; HIV; lamivudine; tenofovir

Indexed keywords

ADEFOVIR; EMTRICITABINE; ENTECAVIR; LAMIVUDINE; STAVUDINE; TELBIVUDINE; TENOFOVIR; ZIDOVUDINE;

EID: 84863224653     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0032-1316466     Document Type: Article
Times cited : (12)

References (60)
  • 1
    • 74549128529 scopus 로고    scopus 로고
    • Epidemiology of hepatitis B and C viruses: A global overview
    • vii
    • Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis: 2010; 14 1 1 21, vii
    • (2010) Clin Liver Dis , vol.14 , Issue.1 , pp. 1-21
    • Te, H.S.1    Jensen, D.M.2
  • 2
    • 20244373332 scopus 로고    scopus 로고
    • Hepatitis B and HIV: Prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort
    • Konopnicki D, Mocroft A, de Wit S., et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS: 2005; 19 2117 2125
    • (2005) AIDS , vol.19 , pp. 2117-2125
    • Konopnicki, D.1    Mocroft, A.2    De Wit, S.3
  • 3
    • 75749135627 scopus 로고    scopus 로고
    • Epidemiology of hepatitis B virus infection in a US cohort of HIV-infected individuals during the past 20 years
    • Infectious Disease Clinical Research Program HIV Working Group
    • Chun HM, Fieberg AM, Hullsiek KH., et al. Infectious Disease Clinical Research Program HIV Working Group Epidemiology of hepatitis B virus infection in a US cohort of HIV-infected individuals during the past 20 years. Clin Infect Dis: 2010; 50 3 426 436
    • (2010) Clin Infect Dis , vol.50 , Issue.3 , pp. 426-436
    • Chun, H.M.1    Fieberg, A.M.2    Hullsiek, K.H.3
  • 4
    • 0042442264 scopus 로고    scopus 로고
    • Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects
    • Kellerman S, Hanson D, McNaghten A, Fleming P. Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. J Infect Dis: 2003; 188 571 577
    • (2003) J Infect Dis , vol.188 , pp. 571-577
    • Kellerman, S.1    Hanson, D.2    McNaghten, A.3    Fleming, P.4
  • 5
    • 77950329915 scopus 로고    scopus 로고
    • Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe
    • EuroSIDA.
    • Soriano V, Mocroft A, Peters L., et al. EuroSIDA. Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe. J Antimicrob Chemother: 2010; 65 3 548 555
    • (2010) J Antimicrob Chemother , vol.65 , Issue.3 , pp. 548-555
    • Soriano, V.1    Mocroft, A.2    Peters, L.3
  • 6
    • 66149175804 scopus 로고    scopus 로고
    • The natural history of chronic hepatitis B virus infection
    • McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology: 2009; 49 5, Suppl S45 S55
    • (2009) Hepatology , vol.49 , Issue.5 SUPPL.
    • McMahon, B.J.1
  • 7
    • 33644858331 scopus 로고    scopus 로고
    • Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
    • Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer-In HBV (the REVEAL-HBV) Study Group
    • Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ.; Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer-In HBV (the REVEAL-HBV) Study Group Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology: 2006; 130 3 678 686
    • (2006) Gastroenterology , vol.130 , Issue.3 , pp. 678-686
    • Iloeje, U.H.1    Yang, H.I.2    Su, J.3    Jen, C.L.4    You, S.L.5    Chen, C.J.6
  • 8
    • 29944436855 scopus 로고    scopus 로고
    • Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
    • REVEAL-HBV Study Group
    • Chen CJ, Yang HI, Su J., et al. REVEAL-HBV Study Group Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA: 2006; 295 1 65 73
    • (2006) JAMA , vol.295 , Issue.1 , pp. 65-73
    • Chen, C.J.1    Yang, H.I.2    Su, J.3
  • 9
    • 30144442223 scopus 로고    scopus 로고
    • Natural history of chronic hepatitis B in co-infected patients
    • Puoti M, Torti C, Bruno R, Filice G, Carosi G. Natural history of chronic hepatitis B in co-infected patients. J Hepatol: 2006; 44 1, Suppl S65 S70
    • (2006) J Hepatol , vol.44 , Issue.1 SUPPL.
    • Puoti, M.1    Torti, C.2    Bruno, R.3    Filice, G.4    Carosi, G.5
  • 10
    • 79954708052 scopus 로고    scopus 로고
    • Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006
    • Walter SR, Thein HH, Amin J., et al. Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006. J Hepatol: 2011; 54 5 879 886
    • (2011) J Hepatol , vol.54 , Issue.5 , pp. 879-886
    • Walter, S.R.1    Thein, H.H.2    Amin, J.3
  • 11
    • 78650307553 scopus 로고    scopus 로고
    • Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues
    • Martín-Carbonero L, Teixeira T, Poveda E., et al. Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues. AIDS: 2011; 25 1 73 79
    • (2011) AIDS , vol.25 , Issue.1 , pp. 73-79
    • Martín-Carbonero, L.1    Teixeira, T.2    Poveda, E.3
  • 12
    • 55249118634 scopus 로고    scopus 로고
    • Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma
    • Swiss HIV Cohort.
    • Clifford GM, Rickenbach M, Polesel J., et al. Swiss HIV Cohort. Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma. AIDS: 2008; 22 16 2135 2141
    • (2008) AIDS , vol.22 , Issue.16 , pp. 2135-2141
    • Clifford, G.M.1    Rickenbach, M.2    Polesel, J.3
  • 13
    • 66149187114 scopus 로고    scopus 로고
    • Hepatitis B and human immunodeficiency virus coinfection
    • Thio CL. Hepatitis B and human immunodeficiency virus coinfection. Hepatology: 2009; 49 5, Suppl S138 S145
    • (2009) Hepatology , vol.49 , Issue.5 SUPPL.
    • Thio, C.L.1
  • 14
    • 85062055676 scopus 로고    scopus 로고
    • Liver-related deaths in persons with the human immunodeficiency virus: The D:A:D study
    • Weber R, Sabin C, Friis-Moller N., et al. Liver-related deaths in persons with the human immunodeficiency virus: the D:A:D study. Arch Intern Med: 2006; 166 1632 1641
    • (2006) Arch Intern Med , vol.166 , pp. 1632-1641
    • Weber, R.1    Sabin, C.2    Friis-Moller, N.3
  • 15
    • 66949175946 scopus 로고    scopus 로고
    • Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: A cohort study and meta-analysis
    • Nikolopoulos GK, Paraskevis D, Hatzitheodorou E., et al. Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis. Clin Infect Dis: 2009; 48 12 1763 1771
    • (2009) Clin Infect Dis , vol.48 , Issue.12 , pp. 1763-1771
    • Nikolopoulos, G.K.1    Paraskevis, D.2    Hatzitheodorou, E.3
  • 16
    • 0037079352 scopus 로고    scopus 로고
    • HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)
    • Multicenter AIDS Cohort Study.
    • Thio CL, Seaberg EC, Skolasky R Jr., et al. Multicenter AIDS Cohort Study. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet: 2002; 360 9349 1921 1926
    • (2002) Lancet , vol.360 , Issue.9349 , pp. 1921-1926
    • Thio, C.L.1    Seaberg, E.C.2    Skolasky Jr., R.3
  • 17
    • 70349902495 scopus 로고    scopus 로고
    • Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria
    • Idoko J, Meloni S, Muazu M., et al. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria. Clin Infect Dis: 2009; 49 1268 1273
    • (2009) Clin Infect Dis , vol.49 , pp. 1268-1273
    • Idoko, J.1    Meloni, S.2    Muazu, M.3
  • 18
    • 77949566352 scopus 로고    scopus 로고
    • Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruption
    • SMART INSIGHT study group
    • Dore GJ, Soriano V, Rockstroh J., et al. SMART INSIGHT study group Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruption. AIDS: 2010; 24 6 857 865
    • (2010) AIDS , vol.24 , Issue.6 , pp. 857-865
    • Dore, G.J.1    Soriano, V.2    Rockstroh, J.3
  • 19
    • 70249142882 scopus 로고    scopus 로고
    • Hepatitis B and long-term HIV outcomes in coinfected HAART recipients
    • Hoffmann CJ, Seaberg EC, Young S., et al. Hepatitis B and long-term HIV outcomes in coinfected HAART recipients. AIDS: 2009; 23 14 1881 1889
    • (2009) AIDS , vol.23 , Issue.14 , pp. 1881-1889
    • Hoffmann, C.J.1    Seaberg, E.C.2    Young, S.3
  • 20
    • 0034606721 scopus 로고    scopus 로고
    • Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection
    • Sulkowski M, Thomas D, Chaisson R., et al. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA: 2000; 283 74 80
    • (2000) JAMA , vol.283 , pp. 74-80
    • Sulkowski, M.1    Thomas, D.2    Chaisson, R.3
  • 21
    • 0036153954 scopus 로고    scopus 로고
    • Hepatotoxicity development during antiretroviral therapy containing protease inhibitors in patients with HIV: The role of hepatitis B and C virus infection
    • LIVERHAART Group
    • Aceti A, Pasquazzi C, Zechini B, De Bac C.; LIVERHAART Group Hepatotoxicity development during antiretroviral therapy containing protease inhibitors in patients with HIV: the role of hepatitis B and C virus infection. J Acquir Immune Defic Syndr: 2002; 29 1 41 48
    • (2002) J Acquir Immune Defic Syndr , vol.29 , Issue.1 , pp. 41-48
    • Aceti, A.1    Pasquazzi, C.2    Zechini, B.3    De Bac, C.4
  • 22
    • 37349034179 scopus 로고    scopus 로고
    • Antiretroviral drugs and liver injury
    • Soriano V, Puoti M, Garcia-Gascó P., et al. Antiretroviral drugs and liver injury. AIDS: 2008; 22 1 1 13
    • (2008) AIDS , vol.22 , Issue.1 , pp. 1-13
    • Soriano, V.1    Puoti, M.2    Garcia-Gascó, P.3
  • 23
    • 7744230430 scopus 로고    scopus 로고
    • Survival in patients with HIV infection and viral hepatitis B or C: A cohort study
    • Bonacini M, Louie S, Bzowej N, Wohl AR. Survival in patients with HIV infection and viral hepatitis B or C: a cohort study. AIDS: 2004; 18 15 2039 2045
    • (2004) AIDS , vol.18 , Issue.15 , pp. 2039-2045
    • Bonacini, M.1    Louie, S.2    Bzowej, N.3    Wohl, A.R.4
  • 25
    • 84858138940 scopus 로고    scopus 로고
    • European AIDS Clinical Society Version 6.0, October Available at Accessed December 2, 2011
    • European AIDS Clinical Society. European AIDS Clinical Society Guidelines. Version 6.0, October, 2011. Available at: http://www. europeanaidsclinicalsociety.org. Accessed December 2, 2011
    • (2011) European AIDS Clinical Society Guidelines
  • 26
    • 49849099939 scopus 로고    scopus 로고
    • Care of HIV patients with chronic hepatitis B: Updated recommendations from the HIV-Hepatitis B Virus International Panel
    • Soriano V, Puoti M, Peters M., et al. Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel. AIDS: 2008; 22 12 1399 1410
    • (2008) AIDS , vol.22 , Issue.12 , pp. 1399-1410
    • Soriano, V.1    Puoti, M.2    Peters, M.3
  • 27
    • 78649711070 scopus 로고    scopus 로고
    • Long-term therapy with tenofovir is effective for patients coinfected with human immunodeficiency virus and hepatitis B virus
    • Vries-Sluijs T, Reijnders J, Hansen B., et al. Long-term therapy with tenofovir is effective for patients coinfected with human immunodeficiency virus and hepatitis B virus. Gastroenterology: 2010; 139 1934 1941
    • (2010) Gastroenterology , vol.139 , pp. 1934-1941
    • Vries-Sluijs, T.1    Reijnders, J.2    Hansen, B.3
  • 28
    • 67649467275 scopus 로고    scopus 로고
    • Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: Another benefit of HAART in those with preserved CD4 count
    • Landrum ML, Huppler Hullsiek K, Ganesan A., et al. Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: another benefit of HAART in those with preserved CD4 count. Vaccine: 2009; 27 34 4731 4738
    • (2009) Vaccine , vol.27 , Issue.34 , pp. 4731-4738
    • Landrum, M.L.1    Huppler Hullsiek, K.2    Ganesan, A.3
  • 29
    • 57049153416 scopus 로고    scopus 로고
    • Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients
    • Cruciani M, Mengoli C, Serpelloni G., et al. Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients. Vaccine: 2009; 27 1 17 22
    • (2009) Vaccine , vol.27 , Issue.1 , pp. 17-22
    • Cruciani, M.1    Mengoli, C.2    Serpelloni, G.3
  • 30
    • 27644490225 scopus 로고    scopus 로고
    • Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus
    • Laurence JC. Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus. Am J Med: 2005; 118 Suppl 10A 75S 83S
    • (2005) Am J Med , vol.118 , Issue.SUPPL. 10A
    • Laurence, J.C.1
  • 31
    • 57149091722 scopus 로고    scopus 로고
    • A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update
    • quiz 1286
    • Keeffe EB, Dieterich DT, Han SH., et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. Clin Gastroenterol Hepatol: 2008; 6 12 1315 1341, quiz 1286
    • (2008) Clin Gastroenterol Hepatol , vol.6 , Issue.12 , pp. 1315-1341
    • Keeffe, E.B.1    Dieterich, D.T.2    Han, S.H.3
  • 32
    • 58149296156 scopus 로고    scopus 로고
    • EASL Clinical Practice Guidelines: Management of chronic hepatitis B
    • European Association for the Study of the Liver.
    • European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol: 2009; 50 2 227 242
    • (2009) J Hepatol , vol.50 , Issue.2 , pp. 227-242
  • 33
    • 33645017628 scopus 로고    scopus 로고
    • Confronting chronic hepatitis B virus infection in HIV: New diagnostic tools and more weapons
    • Soriano V, Sheldon J, Ramos B, Núñez M. Confronting chronic hepatitis B virus infection in HIV: new diagnostic tools and more weapons. AIDS: 2006; 20 3 451 453
    • (2006) AIDS , vol.20 , Issue.3 , pp. 451-453
    • Soriano, V.1    Sheldon, J.2    Ramos, B.3    Núñez, M.4
  • 34
    • 79958038529 scopus 로고    scopus 로고
    • Peginterferon alpha-based therapy for chronic hepatitis B focusing on HBsAg clearance or seroconversion: A meta-analysis of controlled clinical trials
    • Li WC, Wang MR, Kong LB, Ren WG, Zhang YG, Nan YM. Peginterferon alpha-based therapy for chronic hepatitis B focusing on HBsAg clearance or seroconversion: a meta-analysis of controlled clinical trials. BMC Infect Dis: 2011; 11 165
    • (2011) BMC Infect Dis , vol.11 , pp. 165
    • Li, W.C.1    Wang, M.R.2    Kong, L.B.3    Ren, W.G.4    Zhang, Y.G.5    Nan, Y.M.6
  • 35
    • 0036892339 scopus 로고    scopus 로고
    • Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B
    • Di Martino V, Thevenot T, Colin JF., et al. Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B. Gastroenterology: 2002; 123 6 1812 1822
    • (2002) Gastroenterology , vol.123 , Issue.6 , pp. 1812-1822
    • Di Martino, V.1    Thevenot, T.2    Colin, J.F.3
  • 36
    • 33644818518 scopus 로고    scopus 로고
    • A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
    • Chang TT, Gish RG, De Man R., et al. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med: 2006; 354 10 1001 1010
    • (2006) N Engl J Med , vol.354 , Issue.10 , pp. 1001-1010
    • Chang, T.T.1    Gish, R.G.2    De Man, R.3
  • 37
    • 33644822860 scopus 로고    scopus 로고
    • Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
    • BEHoLD AI463027 Study Group
    • Lai CL, Shouval D, Lok AS., et al. BEHoLD AI463027 Study Group Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N Engl J Med: 2006; 354 10 1011 1020
    • (2006) N Engl J Med , vol.354 , Issue.10 , pp. 1011-1020
    • Lai, C.L.1    Shouval, D.2    Lok, A.S.3
  • 38
    • 77953430954 scopus 로고    scopus 로고
    • Genotypic determinants and phenotypic properties of antiviral-resistant HBV variants: Insight from entecavir resistance studies
    • Tenney DJ. Genotypic determinants and phenotypic properties of antiviral-resistant HBV variants: insight from entecavir resistance studies. Antivir Ther: 2010; 15 3 Pt B 529 535
    • (2010) Antivir Ther , vol.15 , Issue.3 PART B , pp. 529-535
    • Tenney, D.J.1
  • 39
    • 34250722018 scopus 로고    scopus 로고
    • The HBV drug entecavireffects on HIV-1 replication and resistance
    • McMahon MA, Jilek BL, Brennan TP., et al. The HBV drug entecavireffects on HIV-1 replication and resistance. N Engl J Med: 2007; 356 25 2614 2621
    • (2007) N Engl J Med , vol.356 , Issue.25 , pp. 2614-2621
    • McMahon, M.A.1    Jilek, B.L.2    Brennan, T.P.3
  • 40
    • 79954576654 scopus 로고    scopus 로고
    • New 2011 updated DHHS antiretroviral treatment guidelines and chronic hepatitis B
    • Soriano V, Vispo E, Barreiro P. New 2011 updated DHHS antiretroviral treatment guidelines and chronic hepatitis B. AIDS: 2011; 25 7 1013 1014
    • (2011) AIDS , vol.25 , Issue.7 , pp. 1013-1014
    • Soriano, V.1    Vispo, E.2    Barreiro, P.3
  • 41
    • 79955609622 scopus 로고    scopus 로고
    • Managing hepatitis B/HIV co-infected: Adding entecavir to truv
    • ada (tenofovir disoproxil/emtricitabine) experienced patients
    • Ratcliffe L, Beadsworth M, Pennell A, Fillips M, Vilar FJ. Managing hepatitis B/HIV co-infected: adding entecavir to truv. ada (tenofovir disoproxil/emtricitabine) experienced patients. AIDS: 2011; 25 8 1051 1056
    • (2011) AIDS , vol.25 , Issue.8 , pp. 1051-1056
    • Ratcliffe, L.1    Beadsworth, M.2    Pennell, A.3    Fillips, M.4    Vilar, F.J.5
  • 42
    • 34248188710 scopus 로고    scopus 로고
    • Telbivudine: A new option for the treatment of chronic hepatitis B
    • Ruiz-Sancho A, Sheldon J, Soriano V. Telbivudine: a new option for the treatment of chronic hepatitis B. Expert Opin Biol Ther: 2007; 7 5 751 761
    • (2007) Expert Opin Biol Ther , vol.7 , Issue.5 , pp. 751-761
    • Ruiz-Sancho, A.1    Sheldon, J.2    Soriano, V.3
  • 43
    • 62349140803 scopus 로고    scopus 로고
    • Telbivudine has activity against HIV-1
    • Low E, Cox A, Atkins M, Nelson M. Telbivudine has activity against HIV-1. AIDS: 2009; 23 4 546 547
    • (2009) AIDS , vol.23 , Issue.4 , pp. 546-547
    • Low, E.1    Cox, A.2    Atkins, M.3    Nelson, M.4
  • 44
    • 77952647304 scopus 로고    scopus 로고
    • Telbivudine exhibits no inhibitory activity against HIV-1 clinical isolates in vitro
    • Lin K, Karwowska S, Lam E, Limoli K, Evans TG, Avila C. Telbivudine exhibits no inhibitory activity against HIV-1 clinical isolates in vitro. Antimicrob Agents Chemother: 2010; 54 6 2670 2673
    • (2010) Antimicrob Agents Chemother , vol.54 , Issue.6 , pp. 2670-2673
    • Lin, K.1    Karwowska, S.2    Lam, E.3    Limoli, K.4    Evans, T.G.5    Avila, C.6
  • 45
    • 33745189870 scopus 로고    scopus 로고
    • Mutations affecting the replication capacity of the hepatitis B virus
    • Sheldon J, Rodès B, Zoulim F, Bartholomeusz A, Soriano V. Mutations affecting the replication capacity of the hepatitis B virus. J Viral Hepat: 2006; 13 7 427 434
    • (2006) J Viral Hepat , vol.13 , Issue.7 , pp. 427-434
    • Sheldon, J.1    Rodès, B.2    Zoulim, F.3    Bartholomeusz, A.4    Soriano, V.5
  • 47
    • 34547792213 scopus 로고    scopus 로고
    • A novel mutation pattern emerging during lamivudine treatment shows cross-resistance to adefovir dipivoxil treatment
    • Karatayli E, Karayalçin S, Karaaslan H., et al. A novel mutation pattern emerging during lamivudine treatment shows cross-resistance to adefovir dipivoxil treatment. Antivir Ther: 2007; 12 5 761 768
    • (2007) Antivir Ther , vol.12 , Issue.5 , pp. 761-768
    • Karatayli, E.1    Karayalçin, S.2    Karaaslan, H.3
  • 48
    • 0032760120 scopus 로고    scopus 로고
    • Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients
    • Benhamou Y, Bochet M, Thibault V., et al. Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients. Hepatology: 1999; 30 1302 1306
    • (1999) Hepatology , vol.30 , pp. 1302-1306
    • Benhamou, Y.1    Bochet, M.2    Thibault, V.3
  • 49
    • 55849138005 scopus 로고    scopus 로고
    • Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program
    • Hoffmann CJ, Charalambous S, Martin DJ., et al. Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program. Clin Infect Dis: 2008; 47 11 1479 1485
    • (2008) Clin Infect Dis , vol.47 , Issue.11 , pp. 1479-1485
    • Hoffmann, C.J.1    Charalambous, S.2    Martin, D.J.3
  • 50
    • 55849120853 scopus 로고    scopus 로고
    • Risks and benefits of using antiretroviral therapy in HIV-infected patients with chronic hepatitis B in developing regions
    • Soriano V, Rivas P, Nuñez M. Risks and benefits of using antiretroviral therapy in HIV-infected patients with chronic hepatitis B in developing regions. Clin Infect Dis: 2008; 47 11 1486 1489
    • (2008) Clin Infect Dis , vol.47 , Issue.11 , pp. 1486-1489
    • Soriano, V.1    Rivas, P.2    Nuñez, M.3
  • 51
    • 33646706854 scopus 로고    scopus 로고
    • Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy
    • Matthews GV, Bartholomeusz A, Locarnini S., et al. Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy. AIDS: 2006; 20 6 863 870
    • (2006) AIDS , vol.20 , Issue.6 , pp. 863-870
    • Matthews, G.V.1    Bartholomeusz, A.2    Locarnini, S.3
  • 52
    • 4143053549 scopus 로고    scopus 로고
    • Severe hepatitis and prolonged hepatitis B virus-specific CD8 T-cell response after selection of hepatitis B virus YMDD variant in an HIV/hepatitis B virus-co-infected patient
    • Gouskos T, Wightman F, Chang J., et al. Severe hepatitis and prolonged hepatitis B virus-specific CD8 T-cell response after selection of hepatitis B virus YMDD variant in an HIV/hepatitis B virus-co-infected patient. AIDS: 2004; 18 12 1734 1737
    • (2004) AIDS , vol.18 , Issue.12 , pp. 1734-1737
    • Gouskos, T.1    Wightman, F.2    Chang, J.3
  • 53
    • 33847028842 scopus 로고    scopus 로고
    • Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance
    • Hsu CW, Yeh CT, Chang ML, Liaw YF. Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance. Gastroenterology: 2007; 132 2 543 550
    • (2007) Gastroenterology , vol.132 , Issue.2 , pp. 543-550
    • Hsu, C.W.1    Yeh, C.T.2    Chang, M.L.3    Liaw, Y.F.4
  • 54
    • 41149084629 scopus 로고    scopus 로고
    • Hepatitis B virus escape mutants induced by antiviral therapy
    • Sheldon J, Soriano V. Hepatitis B virus escape mutants induced by antiviral therapy. J Antimicrob Chemother: 2008; 61 4 766 768
    • (2008) J Antimicrob Chemother , vol.61 , Issue.4 , pp. 766-768
    • Sheldon, J.1    Soriano, V.2
  • 55
    • 77950312767 scopus 로고    scopus 로고
    • New paradigms for treating hepatitis B in HIV/hepatitis B virus co-infected patients
    • Martín-Carbonero L, Soriano V. New paradigms for treating hepatitis B in HIV/hepatitis B virus co-infected patients. J Antimicrob Chemother: 2010; 65 3 379 382
    • (2010) J Antimicrob Chemother , vol.65 , Issue.3 , pp. 379-382
    • Martín-Carbonero, L.1    Soriano, V.2
  • 56
    • 25444459427 scopus 로고    scopus 로고
    • Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir
    • Sheldon J, Camino N, Rodés B., et al. Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir. Antivir Ther: 2005; 10 6 727 734
    • (2005) Antivir Ther , vol.10 , Issue.6 , pp. 727-734
    • Sheldon, J.1    Camino, N.2    Rodés, B.3
  • 57
    • 0037016387 scopus 로고    scopus 로고
    • Primary infection with a lamivudine-resistant hepatitis B virus
    • Thibault V, Aubron-Olivier C, Agut H, Katlama C. Primary infection with a lamivudine-resistant hepatitis B virus. AIDS: 2002; 16 1 131 133
    • (2002) AIDS , vol.16 , Issue.1 , pp. 131-133
    • Thibault, V.1    Aubron-Olivier, C.2    Agut, H.3    Katlama, C.4
  • 58
    • 79959482415 scopus 로고    scopus 로고
    • HBV primary drug resistance in newly diagnosed HIV-HBV-coinfected individuals in Spain
    • CoRIS Study Group
    • Tuma P, Pineda JA, Labarga P., et al. CoRIS Study Group HBV primary drug resistance in newly diagnosed HIV-HBV-coinfected individuals in Spain. Antivir Ther: 2011; 16 4 585 589
    • (2011) Antivir Ther , vol.16 , Issue.4 , pp. 585-589
    • Tuma, P.1    Pineda, J.A.2    Labarga, P.3
  • 59
    • 77954658782 scopus 로고    scopus 로고
    • Acute hepatitis B infection associated with drug-resistant hepatitis B virus
    • Xu Z, Liu Y, Xu T., et al. Acute hepatitis B infection associated with drug-resistant hepatitis B virus. J Clin Virol: 2010; 48 4 270 274
    • (2010) J Clin Virol , vol.48 , Issue.4 , pp. 270-274
    • Xu, Z.1    Liu, Y.2    Xu, T.3
  • 60
    • 73149115449 scopus 로고    scopus 로고
    • Lamivudine-resistant mutation among treatment-naïve hepatitis B patients is common and may be associated with treatment failure
    • Abstract presented at October 31-November 4 San Francisco, CA; Abstract 888
    • Fung S, Mazulli T, El-Kashab M., et al. Lamivudine-resistant mutation among treatment-naïve hepatitis B patients is common and may be associated with treatment failure. Abstract presented at: Annual Meeting of the American Association for the Study of Liver Diseases; October 31-November 4, 2008; San Francisco, CA; Abstract 888
    • (2008) Annual Meeting of the American Association for the Study of Liver Diseases
    • Fung, S.1    Mazulli, T.2    El-Kashab, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.